Nov 7 2009
NanoTecNexus (NTN), formerly NanoBioNexus, already acclaimed for its educational forums and nanobiotechnology expertise, announces the launch of new courses, seminars, and lectures to be delivered online with proven and easy to use webinar tools. The webinar series initiative is part of NTN's strategy to reach broad geographically dispersed communities, leverage scientific and business experts worldwide, and deliver the highest caliber content in a cost-effective manner.
Kicking off the initiative is a first of its kind Continuing Medical Education (CME) accredited webinar series entitled "Nanomedicine: New Strategies and Innovations to Understand, Treat, and Monitor Disease" sponsored by the UC San Diego School of Medicine and produced in partnership with the UC San Diego NanoTumor Center (NTC). The first of six sessions is scheduled for Friday November 20, at 11 am Pacific. Brochure and details follow.
The NanoTumor Center, a public-private consortium funded by the National Cancer Institute Alliance for Nanotechnology and led by UC San Diego, is dedicated to the translational application of nanotechnology in the fight against cancer. NanoTecNexus, a member of this consortium and lead for the NTC educational projects, led the planning committee in the design and organization of the webinar series to meet the accreditation standards and requirements.
"Education in the new field of cancer nanotechnology for the scientific and clinical communities as well as the general public is an integral part of our center," said NTC Director Sadik Esener, PhD, Professor of Electrical and Computer Engineering at the UCSD Jacobs School of Engineering.
"The public needs to be aware of and informed about progress in cancer research in key fields such as nanotechnology," noted Dennis Carson, MD, Director of the Moores UCSD Cancer Center, an NTC member. "These types of educational projects are vital to its continued support and success."
The nanomedicine webinar series, the first of many to come, is designed for the clinical and research
communities worldwide as well as industry professionals and general public interested in learning about progress made in medical research. The goal is to educate on the translational progress of applications using nanotechnology to address disease. "We are committed to fill an important void and place the attention on real progress, not just promise or hype," said Adriana Vela, Founder and CEO of NanoTecNexus. "I am proud to say that, since our inception, we have not wavered from delivering quality content." See brochure at ntc-ccne.org/Seminars/nanomed/index.html
Additionally, industry and commercialization focused webinars are planned for delivery in January 2010. Experts in topics ranging from nanotech venture financing and the art of the term sheet to winning strategies for SBIR grant proposals are among commercialization topics being planned. The industry focused segments are designed for entrepreneurial and commercial companies as well as technology and business professionals interested in nanotechnology opportunities. Visit www.nanotecnexus.org for the latest webinar release dates.